Nov 28, 2022
Dr. Tomasz George, Chief Scientific Officer of Virax Biolabs, has developed a novel test process that assesses adaptive immune responses to viruses. This information can inform decisions by patients and doctors on how to most effectively produce an immune response and boost personal protection from the next virus outbreak. An app delivers data about how an individual might respond to a virus and sends notices of specific viruses in a geographic location, along with links to diet and lifestyle suggestions.
Tomasz explains, "We also distribute and sell other viral testing products that look at viruses at different stages of infection and also your immunity at different stages. We intend to provide a subscription service in the next few months that actually allows you to test for these viruses on an ongoing basis, depending on which new viruses are at the moment. And this allows you to determine whether you would expect to cope with these viruses or not if you came in contact with them."
"We have a number of different avenues for selling our tests. We sell direct to consumers because it's a very informative test for people in general population groups. We also are looking to sell to governments, healthcare organizations, and pharma groups who will use our tests in different ways for population health management and management of governmental strategies. And also, for healthcare groups to identify patients who are most at risk and for pharma groups who can help to optimize the population that they study for things like drugs and vaccines by identifying patients who might respond better or worse to specific viruses."
@ViraxBiolabs #ViraxBiolabs #VRAX #ViraxCare #InfectiousDiseases #HealthTech #MedTech #BioTech #RealTimePCRDetection #RTPCR #PCRTest #AntibodyTest #BiomarkerTesting #COVID19